2024 annual financial data
Cardiol Therapeutics 2024 Operating margin
Cardiol Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -40,276,651 CAD and net income was -36,677,299 CAD.
Operating cash flow was -25,060,867 CAD.
Get free Cardiol Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 CAD
- Operating income
- -40,276,651 CAD
- Net income
- -36,677,299 CAD
- Operating cash flow
- -25,060,867 CAD